- Home
- MYNZ vs SPHL Comparison
MYNZ vs SPHL Comparison
Compare MYNZ & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- SPHL
- Stock Information
- Founded
- MYNZ 2021
- SPHL 2002
- Country
- MYNZ Germany
- SPHL Singapore
- Employees
- MYNZ N/A
- SPHL N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- SPHL Homebuilding
- Sector
- MYNZ Health Care
- SPHL Consumer Discretionary
- Exchange
- MYNZ Nasdaq
- SPHL Nasdaq
- Market Cap
- MYNZ 7.6M
- SPHL 6.0M
- IPO Year
- MYNZ 2021
- SPHL 2024
- Fundamental
- Price
- MYNZ $1.90
- SPHL $0.55
- Analyst Decision
- MYNZ Buy
- SPHL
- Analyst Count
- MYNZ 2
- SPHL 0
- Target Price
- MYNZ $14.00
- SPHL N/A
- AVG Volume (30 Days)
- MYNZ 186.6K
- SPHL 101.1K
- Earning Date
- MYNZ 08-05-2025
- SPHL 02-21-2025
- Dividend Yield
- MYNZ N/A
- SPHL N/A
- EPS Growth
- MYNZ N/A
- SPHL N/A
- EPS
- MYNZ N/A
- SPHL N/A
- Revenue
- MYNZ $893,991.00
- SPHL $6,456,601.00
- Revenue This Year
- MYNZ $26.06
- SPHL N/A
- Revenue Next Year
- MYNZ $4.97
- SPHL N/A
- P/E Ratio
- MYNZ N/A
- SPHL N/A
- Revenue Growth
- MYNZ N/A
- SPHL N/A
- 52 Week Low
- MYNZ $1.34
- SPHL $0.35
- 52 Week High
- MYNZ $19.00
- SPHL $7.80
- Technical
- Relative Strength Index (RSI)
- MYNZ 49.46
- SPHL N/A
- Support Level
- MYNZ $1.89
- SPHL N/A
- Resistance Level
- MYNZ $2.07
- SPHL N/A
- Average True Range (ATR)
- MYNZ 0.21
- SPHL 0.00
- MACD
- MYNZ 0.02
- SPHL 0.00
- Stochastic Oscillator
- MYNZ 38.10
- SPHL 0.00
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.